Phase 3 of Covaxin trials kick off at AIIMS, neurology chief gets first dose
By MYBRANDBOOK
Covaxin’s phase 3 trials kicked off at the All India Institute of Medical Sciences (AIIMS), with the vaccine being given to the head of the department of neurology Dr MV Padma Shrivastava.
Unlike the phase 1 and 2 trials, people from the general population - including the young, the old and the comorbid - will be given the vaccine in Phase 2 and not just healthy volunteers.
Over 26,000 volunteers from 25 trial sites across the country will be recruited for the large scale phase 3 trials. In Delhi, doctors from AIIMS will administer the two dose vaccine, developed by an Indian vaccine maker in collaboration with the Indian Council of Medical Research, to 3,000 persons in Delhi’s Dakshinpuri.
“The first person to be enrolled for the phase 3 trial has received the first shot today. Another shot will be given a month later. We hope to complete the enrolment of 3,000 persons within a month. Volunteers would be selected from among AIIMS employees and from a site we have in Dakshinpuri. That will ensure that we are able to do proper follow-ups,” said Dr Puneet Mishra, professor, department of community medicine, AIIMS. He is one of the investigators of the vaccine trial.
“It is my institute’s trial and my country’s product. It is an honour to participate in the trial. All medicines that come into the market have to go through the trial. I understand the science; it is a placebo controlled trial and no one will know who gets the vaccine and who does not, and I am happy to play my part,” said Dr MV Padma Srivastava. The doctor vouched that she is over the age of 60 years and has no comorbidities.
Vaccine candidates have to be tested on animal models first to check their safety and immune response. In humans, a small phase 1 trial is done to check the safety of the compound, while in phase 2; trials are done to see the immune response and the dose at which the vaccine should be administered.
Large scale phase 3 trials are done to see how many infections or severe disease the vaccine prevents in a given population.
“The recruitment should be complete within a month and we will start seeing some preliminary data by that time,” said Dr Mishra.
The people who administered the vaccine will be followed up for a period of 207 days by the researchers. The vaccine uses an inactivated Sars-Cov-2 virus to generate an immune response that can prevent COVID-19 disease. The preliminary data, which can be presented to the drug regulator for seeking emergency use authorisation, should be available within two months, the researcher said.
The doctor said so far, none of the participants in the phase 1 and 2 trials has had any adverse effects, although there have been news reports of a volunteer from Nagpur developing viral pneumonia or inflammation of the lungs.
“Some participants have just experienced redness and pain at the injection site, but that is common to many injectables,” said Dr Mishra.
Apart from Covaxin, ZyCovD developed by Indian pharmaceutical company Zydus is also in advanced stages of human trials.
BREAKING NEWS
TECHNO TRENDS
Nazara and ONDC set to transform in-game monetization with ‘
Nazara Technologies has teamed up with the Open Network for Digital Comme...
Jio Platforms and NICSI to offer cloud services to government
In a collaborative initiative, the National Informatics Centre Services In...
BSNL awards ₹5,000 Cr Project to RVNL-Led Consortium
A syndicate led by Rail Vikas Nigam Limited (abbreviated as RVNL), along wi...
Pinterest tracks users without consent, alleges complaint
A recent complaint alleges that Pinterest, the popular image-sharing platf...
E-Magazine
TECHNOTAINMENT
Netflix adds 'Moments' feature for saving, sharing scenes from
Netflix has introduced a new “Moments” feature on its mobile app, whic
Jacqueline Fernandez come together with YouTuber Mr. Beast for
Jacqueline Fernandez has partnered with American YouTuber Mr. Beast to b
MOVERS & SHAKERS
Visa elevates Rishi Chhabra as new Country Manager for India
Rishi holds a Master’s in Industrial Engineering from The Ohio State Univ
Genesys welcomes Albert Nel as Senior VP and Regional Sales Le
Genesys continues to deepen its investment in the APAC region. Earlier this
OPEN YOUR EYES
INTERVIEWS
Delivering Critical Business Communication Solutions to Enterp
Arya Omnitalk and Syntel’s comprehensive suite of solutions and more than
Cisco building a trusted and resilient future for the nation
Security is foundational to everything Cisco does and customers insist on e
HOT PICK
SonicWall Launches TZ80: A Powerful Solution for Remote Office
SonicWall announced today the launch of the TZ80, a groundbreaking securit
Gigabyte X3D Turbo: A Gaming Revolution
GIGABYTE X3D Turbo Mode is a cutting-edge feature that unifies cores distr
MAKE IN INDIA BRANDS
VVDN TECHNOLOGIES
SAMSUNG INDIA ELECTRONICS LTD.
PDRL - Passenger Drone Research Pvt. Ltd.
TATA CONSULTANCY SERVICES
EMINENT CIO'S OF INDIA
ICONS OF INDIA
ICONS OF INDIA : S KRISHNAN
S Krishnan as the secretary for the electronics and information techno...
Icons Of India : Puneet Chandok
Puneet Chandok is President, Microsoft India & South Asia and is respo...
ICONS OF INDIA : SRIDHAR VEMBU
Sridhar Vembu is the chief executive officer (CEO) of Zoho Corporation...
PARTNER SPEAKERS
PSU
C-DOT - Center of Development of Telematics
India’s premier research and development center focused on telecommu...
EESL - Energy Efficiency Services Limited
EESL is uniquely positioned in India’s energy sector to address ener...
UIDAI - Unique Identification Authority of India
UIDAI and the Aadhaar system represent a significant milestone in Indi...
VIDEOS
Top 25 Brands
Global Indian industry
Indian Tech Talent Excelling The Tech World - George Kurian, CEO, Netapp
George Kurian, the CEO of global data storage and management services ...
Indian Tech Talent Excelling The Tech World - Shantanu Narayen, CEO- Adobe Systems Incorporated
Shantanu Narayen, CEO of Adobe Systems Incorporated, is renowned for h...
Indian Tech Talent Excelling The Tech World - ANJALI SUD, CEO – Tubi
Anjali Sud, the former CEO of Vimeo, now leads Tubi, Fox Corporation...
STARNITE AWARDS 2024
ITFORUM 2024
CMO of the Year
WOMEN LEADERSHIP
IMAGE GALLERY
TRENDS IN TECHNOLOGY
MORE VIDEOS
ADVERTISEMENTS
TECHNOLOGY DISRUPTION
UNICORNS REVOLUTIONISING
